{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:34:01Z","timestamp":1792953241913,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Borenda Biochemical Technology (Shanghai) Co., Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s13555-026-01915-7","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:46:09Z","timestamp":1790243169000},"page":"5555-5566","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supramolecular Salicylic Acid Chemical Peeling Combined with Supramolecular Active Zinc for Malassezia Folliculitis: Efficacy and Safety from a Multicenter, Single-Arm Trial"],"prefix":"10.1007","volume":"16","author":[{"given":"Yuanzhi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingdong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbiao","family":"Wa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-2750","authenticated-orcid":false,"given":"Zhenfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"1915_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fcimb.2020.00112","volume":"10","author":"DML Saunte","year":"2020","unstructured":"Saunte DML, Gaitanis G, Hay RJ. Malassezia-associated skin diseases, the use of diagnostics and treatment. Front Cell Infect Microbiol. 2020;10:112.","journal-title":"Front Cell Infect Microbiol"},{"issue":"9","key":"1915_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010784","volume":"18","author":"K Ehemann","year":"2022","unstructured":"Ehemann K, Mantilla MJ, Mora-Restrepo F, et al. Many ways, one microorganism: several approaches to study Malassezia in interactions with model hosts. PLoS Pathog. 2022;18(9):e1010784.","journal-title":"PLoS Pathog"},{"issue":"4","key":"1915_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12035-024-04270-w","volume":"62","author":"B Naik","year":"2025","unstructured":"Naik B, Sasikumar J, Das SP. From skin and gut to the brain: the infectious journey of the human commensal fungus Malassezia and its neurological consequences. Mol Neurobiol. 2025;62(4):533\u201356.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1915_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24030419","volume":"24","author":"M Gonzalez","year":"2019","unstructured":"Gonzalez M, Celis AM, Guevara-Suarez MI, et al. Yeast smell like what they eat: analysis of volatile organic compounds of Malassezia furfur in growth media supplemented with different lipids. Molecules. 2019;24(3):419.","journal-title":"Molecules"},{"issue":"3","key":"1915_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/archderm.1973.01620180042012","volume":"107","author":"BS Potter","year":"1973","unstructured":"Potter BS, Burgoon CF, Johnson WC. Pityrosporum folliculitis: report of seven cases and review of the Pityrosporum organism relative to cutaneous disease. Arch Dermatol. 1973;107(3):388\u201391.","journal-title":"Arch Dermatol"},{"key":"1915_CR6","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2147\/CCID.S395654","volume":"15","author":"A Paichitrojjana","year":"2022","unstructured":"Paichitrojjana A, Chalermchai T. The prevalence, associated factors, and clinical characterization of Malassezia folliculitis in patients clinically diagnosed with acne vulgaris. Clin Cosmet Investig Dermatol. 2022;15:2647\u201354.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"7","key":"1915_CR7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1111\/jdv.18982","volume":"37","author":"MAS Henning","year":"2023","unstructured":"Henning MAS, Hay R, Rodriguez-Cerdeira C, et al. Position statement: recommendations on the diagnosis and treatment of Malassezia folliculitis. J Eur Acad Dermatol Venereol. 2023;37(7):1268\u201375.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"1915_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00403-005-0594-4","volume":"297","author":"A Baroni","year":"2006","unstructured":"Baroni A, Orlando M, Donnarumma G, et al. Toll-like receptor 2 (TLR2) mediates intracellular signaling in human keratinocytes in response to Malassezia furfur. Arch Dermatol Res. 2006;297(7):280\u20138.","journal-title":"Arch Dermatol Res"},{"issue":"6","key":"1915_CR9","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1007\/s00403-022-02506-0","volume":"315","author":"M Green","year":"2023","unstructured":"Green M, Feschuk AM, Kashetsky N, et al. Clinical characteristics and treatment outcomes of Pityrosporum folliculitis in immunocompetent patients. Arch Dermatol Res. 2023;315(6):1497\u2013509.","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"1915_CR10","doi-asserted-by":"publisher","first-page":"AB159","DOI":"10.1016\/j.jaad.2016.02.627","volume":"74","author":"FW Danby","year":"2016","unstructured":"Danby FW. Malassezia infections\u2014management with pulsed oral ketoconazole. J Am Acad Dermatol. 2016;74(5):AB159.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1915_CR11","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1111\/jocd.14799","volume":"21","author":"L Zhang","year":"2022","unstructured":"Zhang L, Shao X, Chen Y, et al. 30% supramolecular salicylic acid peels effectively treats acne vulgaris and reduces facial sebum. J Cosmet Dermatol. 2022;21(8):3398\u2013405.","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"1915_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/ajd.12715","volume":"59","author":"AA O\u2019Connor","year":"2018","unstructured":"O\u2019Connor AA, Lowe PM, Shumack S, et al. Chemical peels: a review of current practice. Australas J Dermatol. 2018;59(3):171\u201381.","journal-title":"Australas J Dermatol"},{"issue":"1","key":"1915_CR13","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2020\/e1875","volume":"75","author":"RL Gu","year":"2020","unstructured":"Gu RL, Wang SQ. Clinical study on treatment of facial seborrheic dermatitis with intense pulsed light combined with 30% supramolecular salicylic acid. Clinics (Sao Paulo). 2020;75(1):e1875.","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"1915_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s13555-022-00844-5","volume":"13","author":"X Shao","year":"2023","unstructured":"Shao X, Chen Y, Zhang L, et al. Effect of 30% supramolecular salicylic acid peel on skin microbiota and inflammation in patients with moderate-to-severe acne vulgaris. Dermatol Ther. 2023;13(1):155\u201368.","journal-title":"Dermatol Ther"},{"issue":"2","key":"1915_CR15","first-page":"140","volume":"15","author":"JR Schwartz","year":"2016","unstructured":"Schwartz JR. Zinc pyrithione: a topical antimicrobial with complex pharmaceutics. J Drugs Dermatol. 2016;15(2):140\u20134.","journal-title":"J Drugs Dermatol"},{"issue":"Suppl 2","key":"1915_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2133.2011.10571.x","volume":"165","author":"NL Reeder","year":"2011","unstructured":"Reeder NL, Xu J, Youngquist RS, et al. The antifungal mechanism of action of zinc pyrithione. Br J Dermatol. 2011;165(Suppl 2):9\u201312.","journal-title":"Br J Dermatol"},{"issue":"3","key":"1915_CR17","doi-asserted-by":"publisher","first-page":"E63","DOI":"10.3314\/mmj.16-00003","volume":"57","author":"C Suzuki","year":"2016","unstructured":"Suzuki C, Hase M, Shimoyama H, et al. Treatment outcomes for Malassezia folliculitis in the dermatology department of a university hospital in Japan. Med Mycol J. 2016;57(3):E63\u20136.","journal-title":"Med Mycol J"},{"issue":"2","key":"1915_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/lsm.20857","volume":"42","author":"JW Lee","year":"2010","unstructured":"Lee JW, Kim BJ, Kim MN. Photodynamic therapy: new treatment for recalcitrant Malassezia folliculitis. Lasers Surg Med. 2010;42(2):192\u20136.","journal-title":"Lasers Surg Med"},{"key":"1915_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2147\/CCID.S84765","volume":"8","author":"T Arif","year":"2015","unstructured":"Arif T. Salicylic acid as a peeling agent: a comprehensive review. Clin Cosmet Investig Dermatol. 2015;8:455\u201361.","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"6","key":"1915_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1111\/jocd.16238","volume":"23","author":"CX Ye","year":"2024","unstructured":"Ye CX, Yi J, Su Z, et al. 2% supramolecular salicylic acid hydrogel vs adapalene gel in mild to moderate acne vulgaris treatment: a multicenter, randomized, evaluator-blind, parallel-controlled trial. J Cosmet Dermatol. 2024;23(6):2125\u201334.","journal-title":"J Cosmet Dermatol"},{"issue":"10","key":"1915_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/ced\/llad168","volume":"48","author":"C Yu","year":"2023","unstructured":"Yu C, Yu N, Jiang X, et al. Efficacy and safety of supramolecular active zinc in the treatment of scalp psoriasis: a multicentre, randomized, observer-blind, parallel-group, placebo and active-controlled non-inferiority trial. Clin Exp Dermatol. 2023;48(10):1138\u201344.","journal-title":"Clin Exp Dermatol"},{"key":"1915_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2147\/DDDT.S397541","volume":"17","author":"C Zhou","year":"2023","unstructured":"Zhou C, Hua C, Liang Q, et al. 0.5\u20135% supramolecular salicylic acid hydrogel is safe for long-term topical application and improves the expression of genes related to skin barrier homeostasis in mice models. Drug Des Devel Ther. 2023;17:1593\u2013609.","journal-title":"Drug Des Devel Ther"},{"issue":"3","key":"1915_CR23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1346-8138.1998.tb02377.x","volume":"25","author":"D Parsad","year":"1998","unstructured":"Parsad D, Saini R, Negi KS. Comparison of oral fluconazole and oral ketoconazole in the treatment of Malassezia (Pityrosporum) folliculitis. J Dermatol. 1998;25(3):185\u20138.","journal-title":"J Dermatol"},{"issue":"11","key":"1915_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0151-9638(07)92824-0","volume":"134","author":"A L\u00e9vy","year":"2007","unstructured":"L\u00e9vy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B. Malassezia folliculitis: characteristics and therapeutic response in 26 patients. Ann Dermatol Venereol. 2007;134(11):823\u20138.","journal-title":"Ann Dermatol Venereol"},{"issue":"3","key":"1915_CR25","first-page":"37","volume":"7","author":"RM Rubenstein","year":"2014","unstructured":"Rubenstein RM, Malerich SA. Malassezia (pityrosporum) folliculitis. J Clin Aesthet Dermatol. 2014;7(3):37\u201341.","journal-title":"J Clin Aesthet Dermatol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01915-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T18:00:53Z","timestamp":1792951253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01915-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01915-7","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"assertion":[{"value":"26 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Yuanzhi Liu, Jinjin Zhang, Wei Lai, Xingdong Ye, Yanhua Liang, Xiuli Wang, Shanshan Li, Weihui Zeng, Hong Fang, Qingbiao Wa, Xiujuan Wu, Ningjing Song, Bin Yang, and Zhenfeng Liu declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Medical Ethics Committees of all 11 participating hospitals (lead approval: Dermatology Hospital of Southern Medical University, approval no. 2021061). The study was conducted in accordance with the Declaration of Helsinki. All participants provided written informed consent to participate, and consent for publication was obtained for recognizable clinical photographs.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}